Omeprazole and reflux disease - improvement of clinical outcome by genotype-adjusted dosing - GERD-Studie
- Conditions
- gastrooesophageal reflux disease (GERD)
- Registration Number
- EUCTR2006-004650-24-DE
- Lead Sponsor
- IKP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Reflux Oesophagitis grade A and B
Body Mass Index 20-30
Age 20-70 years
written informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients with known sensitivity to omeprazole
deficiency of lactase
pregnancy
no written informed consent
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method